2020/1 GaBI Journal Table of Contents

Contents

Editor’s Letter

Editor’s introduction to the initial issue of the ninth volume of GaBI Journal

Original Research

Stability of the trastuzumab biosimilar ABP 980 compared to reference product after intravenous bag preparation, transport and storage at various temperatures, concentrations and stress conditions

Pharmaceutical pricing policy in Saudi Arabia: findings and implications

Perspective

An evolving role for non-governmental organizations dealing with registration backlogs and rising costs: the example of cancer biosimilars in South Africa

Legal

It is time to change U.S. trade policy to foster access to medicines

Opinion

Overview of non-innovator biological products in India

Pharma News

Top developments in biosimilars during 2019

Source URL: https://gabi-journal.net/2020-1-gabi-journal-table-of-contents.html